Overview
- 28 inspections across 28 sites are on record.
- 36 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-15.
At a glance
Inspections
28
Sites
28
Observations
36
Career since
Apr 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Neutraderm, Inc. | 15 Jun 2026 | Human Drugs | On file |
| kdc/one Chatsworth, Inc. | 3 Apr 2026 | Human Drugs | View 483 → |
| Pacira Pharmaceuticals, Inc. | 25 Mar 2026 | Human Drugs | On file |
| Nissan Chemical Corporation | 21 Nov 2025 | Human Drugs | On file |
| Ajinomoto Co., Inc. | 14 Nov 2025 | Human Drugs | On file |
Sites inspected
Neutraderm, Inc.Chatsworth, United States1 insp.
kdc/one Chatsworth, Inc.Chatsworth, United States1 insp.
Pacira Pharmaceuticals, Inc.San Diego, United States1 insp.
Nissan Chemical CorporationSanyo-Onoda, Japan1 insp.
Ajinomoto Co., Inc.Yokkaichi, Japan1 insp.
Co-investigators
Investigators who share inspections with this person.
Gloria E Andia3 shared
Kham Phommachanh3 shared
Rowena S Nguyen3 shared
Alexandra A Cole2 shared
Lillian S Wu2 shared
Khoa Nathan V Tran2 shared
Nicholas L Hunt2 shared
Roger F Zabinski2 shared
Ana-Maria A Plapcianu1 shared
Homero W Aguilar1 shared
Full investigator report
Get the verbatim findings behind Sara H Gabel's 36 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site